Microbes and Medicine—Papers from the 2025 OBASM Meeting
A special issue of Drugs and Drug Candidates (ISSN 2813-2998).
Deadline for manuscript submissions: 30 October 2025 | Viewed by 441
Special Issue Editors
Interests: bacteriophage; phage therapy; host range; phage evolution; phage receptor; phage-host co-evolution
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The 2025 annual meeting of the Ohio Branch of the American Society for Microbiology (OBASM) will be held April 4–5 at Otterbein University in Westerville, Ohio. The conference has been designed to provide an overview of all aspects of microbiology, with sessions designed for senior through student researchers. Sessions include talks focusing on medical microbiology and environmental microbiology, examining basic science and applications. More information about the conference can be found at https://ohiobranchasm.org/meetings/meeting-information.
Meeting participants are invited to contribute articles to a Special Issue of Drugs and Drug Candidates. Articles should fall within the scope of the journal, including, but not limited to, papers on
- Development of new drugs for infectious diseases;
- Studies of genes that could be potential targets for therapeutic agents;
- Microbiome modification;
- Strategies to overcome antimicrobial agent resistance;
- In vitro and in vivo model evaluation and efficacy testing.
Both review and research articles are sought. Please reach out to the guest editors for questions concerning whether a paper will fit with this Special Issue. While authors do not need to have attended the meeting, the journal has generously waived the article processing fees for attendees of the 2025 OBASM meeting.
Prof. Dr. Paul Hyman
Dr. Jennifer A. Bennett
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Drugs and Drug Candidates is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antibiotics
- antibiotic discovery
- antibiotic resistance (or antimicrobial resistance)
- drug design
- drug discovery
- medical microbiology
- microbiology
- microbes
- microbiome
- phage therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
